Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/23/2004 | US20040259790 Methods for identifying and administering agents that bias the immune response via dendritic cells |
12/23/2004 | US20040259767 Antiproliferative agents; therapy for human progessive leukoencephalophy ; suppression of dna viruses; anticancer agents |
12/23/2004 | US20040259733 transforming a cell with a nucleotide sequence by using a microflow nebulizer to form aerosol droplets of a nucleic acid solution, and accelerating the droplets toward the cell; genetic engineering |
12/23/2004 | US20040259255 Helper virus-free AAV production |
12/23/2004 | US20040259254 for use treating various neurodegenerative or brain disorders or injuries via cell transplantation; incubating the cell derived from a mononuclear cell fraction isolated from bone marrow fluid or umbilical blood in a basal culture medium at given temperature range |
12/23/2004 | US20040259249 Method of making stem cells from differentiated cells |
12/23/2004 | US20040259248 RNA interference mediating small RNA molecules |
12/23/2004 | US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference) |
12/23/2004 | US20040259246 Liver cell progenitor and use for treatment of liver diseases |
12/23/2004 | US20040259245 Complete nutrient medium for use as a cosmetic and cosmetic use thereof |
12/23/2004 | US20040259244 converting differentiated non-hormone producing pancreatic cells into differentiated hormone producing cells by converting said non-hormone cells into stem cells; and then culturing stem cells under conditions which differentiate them into hormone-producing cells; use in diabetes therapy |
12/23/2004 | US20040259243 using a cell line with increased sensitivity for infection for the rapid detection of enterovirus by innoculating the cells with the sample and observing; poliovirus, Coxsackie A virus, Coxsackie B virus, or echovirus; using transgenic buffalo green monkey kidney cell lines; producing enteroviruses |
12/23/2004 | US20040259229 Novel technology for genetic mapping |
12/23/2004 | US20040259222 Novel group of $g(a)-amylases and a method for identification and production of novel $g(a)-amylases |
12/23/2004 | US20040259208 Such as mounse transthyretin (mTTR) promoter (antibody); recombinant lentiviruses and transfer vectors for transgene delivery and gene therapy; blood coagulation factor IX; antihemopohilic factor |
12/23/2004 | US20040259201 Recombinant surfactant protein D compositions and methods of use thereof |
12/23/2004 | US20040259196 T cell receptor variants expressed in mesenchymal cells and uses thereof |
12/23/2004 | US20040259194 Cell line and uses thereof |
12/23/2004 | US20040259190 Compositions and methods for production and use of an injectable naturally secreted extracellular matrix |
12/23/2004 | US20040259177 Three dimensional cell cultures in a microscale fluid handling system |
12/23/2004 | US20040259174 designated SM047, as diagnostic aid; test kits; hybridomas that make said antibody |
12/23/2004 | US20040259171 P2Y4 antibody and methods of use |
12/23/2004 | US20040259165 Non-oligomerizing tandem fluorescent proteins |
12/23/2004 | US20040259143 used to screen for agonists and antagonists that can either stimulate or inhibit type V adenylyl cyclase activity |
12/23/2004 | US20040259139 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
12/23/2004 | US20040259123 isolated from Aeropyrum pernix, can stand heat treatment at 100 degrees C. and not lose its activity; host cells, nucleotide sequences, and vectors |
12/23/2004 | US20040259110 Gene PRV-1 and its use |
12/23/2004 | US20040259092 Nogo receptor homologues and their use |
12/23/2004 | US20040259072 Liquid nitrogen-resistant tube, with sliding cylindrical protective member, which is heat sealed |
12/23/2004 | US20040258765 Topical antiulcer and wound healing agent comprising bee pollen, bee propolis, honey, and/or royal jelly; and caffeine; health beverages; skin disorders, herpes viral infections; spray, shampoo, soap, lipstick, or adhesive bandages |
12/23/2004 | US20040258726 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
12/23/2004 | US20040258708 Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapy |
12/23/2004 | US20040258704 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
12/23/2004 | US20040258689 Augmenting activin induced signaling in cells; screening for complex inhibitors; treatment of reproductive, developmental, skin, bone, hepatic, hematopoietic and/or central nervous system disorders; prostrate cancer |
12/23/2004 | US20040258688 Long lasting immunity using single dose at low concentration; exposing dendritic cells to antigen-antibody-DEC-205 receptor conjugate or to recombinant anti-DEC-205 antibody and promoting maturation |
12/23/2004 | US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies |
12/23/2004 | US20040258675 Novel mutated form of arginine deiminase |
12/23/2004 | US20040258673 Elective collection and banking of autologous peripheral blood stem cells |
12/23/2004 | US20040258672 Graft acceptance through manipulation of thymic regeneration |
12/23/2004 | US20040258670 Introducing enriched human endothelial generating cells and mesenchymal stem cells; enhancing vasculogenesis and collateralization around blocked and/or narrowed vessels |
12/23/2004 | US20040258669 Enhancing viability, imparting apoptosis resistance; treating cardiac disorders; reducing scar formation |
12/23/2004 | US20040258661 Generation of use of tc1 and tc2 cells |
12/23/2004 | CA2529016A1 Method and system for the analysis of high density cells samples |
12/23/2004 | CA2528948A1 Mutants of core 2 b-1,6-n-acetylglycosaminyltransferase |
12/23/2004 | CA2528679A1 Cartilage-derived stem cells and applications thereof |
12/23/2004 | CA2528418A1 Method to increase protein production in culture |
12/23/2004 | CA2528399A1 A method for cell implantation |
12/23/2004 | CA2528240A1 Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof |
12/23/2004 | CA2527847A1 Enhancement of oligodendrocyte differentiation |
12/23/2004 | CA2527822A1 Room temperature storage of organs |
12/23/2004 | CA2525584A1 Transgenic animal having an amyloid precursor protein with a modified beta secretase cleavage site |
12/22/2004 | EP1489183A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
12/22/2004 | EP1489170A1 Transporter selectively transporting sulfate conjugate and its gene |
12/22/2004 | EP1489168A1 Protein sustaining undifferentiated stem cells as such |
12/22/2004 | EP1489167A1 Immobilized cells and liposomes and method of immobilizing the same |
12/22/2004 | EP1489163A1 Method of inducing growth of nerve stem cells |
12/22/2004 | EP1489098A1 Production of hybridoma producing antihuman cenp-a peptide monoclonal antibody and method of using the same |
12/22/2004 | EP1488817A1 Microstructured polyphosphazene-containing substrates |
12/22/2004 | EP1488805A2 CD28 pathway immunoregulation |
12/22/2004 | EP1487981A2 Growth regulating proteins |
12/22/2004 | EP1487980A1 Modified gene-silencing rna and uses thereof |
12/22/2004 | EP1487975A2 Serine hydroxymethyltransferase as a target for herbicides |
12/22/2004 | EP1487972A2 Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use |
12/22/2004 | EP1487971A2 MEANS AND METHODS FOR MANIPULATING HYPERSENSITIVITY−LIKE RESPONSES |
12/22/2004 | EP1487970A2 Tolerogenic antigen-presenting cells |
12/22/2004 | EP1487968A1 Methods of inducing differentiation of stem cells into a specific cell lineage |
12/22/2004 | EP1487967A2 Chimeric pancreas |
12/22/2004 | EP1487965A2 Minicell compositions and methods |
12/22/2004 | EP1487874A1 Falp proteins |
12/22/2004 | EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
12/22/2004 | EP1487865A2 USES OF MAMMALIAN CYTOKINEi; RELATED REAGENTS |
12/22/2004 | EP1487857A1 Lymphatic and blood endothelial cell genes |
12/22/2004 | EP1487856A2 Human antibodies specific to kdr and uses thereof |
12/22/2004 | EP1487852A1 Anti-protozoal vaccine |
12/22/2004 | EP1487499A2 Contrast agents for magnetic resonance imaging and methods related thereto |
12/22/2004 | EP1487483A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
12/22/2004 | EP1487480A2 Fusion molecules and methods for treatment of immune diseases |
12/22/2004 | EP1487479A2 Mutant glycoproteins |
12/22/2004 | EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha |
12/22/2004 | EP1487463A2 Local production and/or delivery of anti-cancer agents by stromal cell precursors |
12/22/2004 | EP1487274A2 Tissue engineering |
12/22/2004 | EP1453949A4 Production of cell suspensions |
12/22/2004 | EP1363961A4 End group activated polymers with oligonucleotide ligands |
12/22/2004 | EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
12/22/2004 | EP1272629A4 Genetic silencing |
12/22/2004 | EP1221053A4 A method for isolation of prostatic epithelial cells from semen |
12/22/2004 | EP0857202B1 Method for inhibiting chymopapain and papain enzyme activity with polysaccharides of animal origin |
12/22/2004 | EP0658200B1 Glucagon receptors |
12/22/2004 | CN1556854A Activation and expansion of cells |
12/22/2004 | CN1556816A Application of cardiokinetic hormone in liver disease |
12/22/2004 | CN1556814A Knock in transgenic mammal containing a non-functional N-terminus of Kv beta 1.1 subunit |
12/22/2004 | CN1556204A Anti prourokinase monoclonal antibody hybrid oma cell line and its application |
12/22/2004 | CN1556203A Aimal cell multipore micro carrier immobilized high efficiency culturing method and its culturing medium |
12/22/2004 | CN1556202A Polypore microcarrier for animal cell culturing, its preparation method and special acute hole sprayer |
12/22/2004 | CN1556201A Solid liquid two step culturing method for producing useful metabolism product in plant cell culturing |
12/22/2004 | CN1556200A Method of obtaining saline cistanche phenylethanol glycoside kind compound using bio-conversion technique |
12/22/2004 | CN1556199A Large scale high density culturing method saussurea involucrata cell line TUIP-8 of stable high yield flavone |
12/22/2004 | CN1556198A Perfusion culturing method of hemopoietic cell in agitation type bioreactor |
12/22/2004 | CN1556197A Method of prodcing megacaryocyle using umbilical blood CD 344+cell in vitro induction method |
12/22/2004 | CN1555692A Salt tolerance cotton breeding method |